

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.32797536 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.29895139 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.42257180 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.42257180 |
| 5 | response to peptidoglycan (GO:0032494) | 5.40768211 |
| 6 | respiratory burst (GO:0045730) | 5.29235057 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 5.04153134 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.95979123 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.95979123 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.95979123 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.95979123 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.95979123 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.95979123 |
| 14 | cellular extravasation (GO:0045123) | 4.52350502 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50502631 |
| 16 | neutrophil activation (GO:0042119) | 4.36172758 |
| 17 | response to interleukin-15 (GO:0070672) | 4.30929414 |
| 18 | positive regulation of mast cell activation (GO:0033005) | 4.30639784 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 4.29420589 |
| 20 | positive regulation of mast cell degranulation (GO:0043306) | 4.23060921 |
| 21 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.23060921 |
| 22 | granulocyte activation (GO:0036230) | 4.20137254 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19420113 |
| 24 | leukocyte aggregation (GO:0070486) | 4.16528526 |
| 25 | cytidine metabolic process (GO:0046087) | 4.15408320 |
| 26 | cytidine catabolic process (GO:0006216) | 4.15408320 |
| 27 | cytidine deamination (GO:0009972) | 4.15408320 |
| 28 | regulation of mast cell degranulation (GO:0043304) | 4.14522666 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 4.12042634 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.05842568 |
| 31 | regulation of mast cell activation (GO:0033003) | 4.02987965 |
| 32 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.00358092 |
| 33 | myeloid cell activation involved in immune response (GO:0002275) | 3.97907646 |
| 34 | neutrophil mediated immunity (GO:0002446) | 3.94386229 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.93511372 |
| 36 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.92495330 |
| 37 | B cell mediated immunity (GO:0019724) | 3.90119573 |
| 38 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.86829599 |
| 39 | positive regulation of interferon-alpha production (GO:0032727) | 3.81488971 |
| 40 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.80005174 |
| 41 | T cell migration (GO:0072678) | 3.70404561 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 3.70214324 |
| 43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.70072112 |
| 44 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.69503416 |
| 45 | mast cell activation (GO:0045576) | 3.69414605 |
| 46 | superoxide anion generation (GO:0042554) | 3.64961759 |
| 47 | defense response to protozoan (GO:0042832) | 3.62094270 |
| 48 | regulation of interferon-alpha production (GO:0032647) | 3.60636351 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.58122916 |
| 50 | response to interferon-beta (GO:0035456) | 3.53888225 |
| 51 | response to host immune response (GO:0052572) | 3.53093729 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.53093729 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.52444551 |
| 54 | regulation of T cell tolerance induction (GO:0002664) | 3.52190618 |
| 55 | detection of biotic stimulus (GO:0009595) | 3.49990896 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.49006833 |
| 57 | reactive oxygen species biosynthetic process (GO:1903409) | 3.46993222 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.46627472 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.46078607 |
| 60 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.44854878 |
| 61 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.44410265 |
| 62 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.43877906 |
| 63 | regulation of B cell differentiation (GO:0045577) | 3.43303104 |
| 64 | pinocytosis (GO:0006907) | 3.42590871 |
| 65 | negative regulation of T cell mediated immunity (GO:0002710) | 3.39568538 |
| 66 | response to protozoan (GO:0001562) | 3.37592834 |
| 67 | leukocyte mediated cytotoxicity (GO:0001909) | 3.37576284 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 3.37097254 |
| 69 | detection of other organism (GO:0098543) | 3.36933120 |
| 70 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.36699052 |
| 71 | regulation of tolerance induction (GO:0002643) | 3.35123623 |
| 72 | negative T cell selection (GO:0043383) | 3.34765643 |
| 73 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.33546266 |
| 74 | negative thymic T cell selection (GO:0045060) | 3.30421037 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28065651 |
| 76 | leukocyte degranulation (GO:0043299) | 3.27734038 |
| 77 | myeloid dendritic cell activation (GO:0001773) | 3.25691944 |
| 78 | neutrophil chemotaxis (GO:0030593) | 3.25380655 |
| 79 | positive thymic T cell selection (GO:0045059) | 3.24929227 |
| 80 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.24403140 |
| 81 | negative regulation of mast cell activation (GO:0033004) | 3.23255933 |
| 82 | lymphocyte chemotaxis (GO:0048247) | 3.22999410 |
| 83 | response to host (GO:0075136) | 3.21338603 |
| 84 | response to host defenses (GO:0052200) | 3.21338603 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21338603 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.20868144 |
| 87 | regulation of antigen processing and presentation (GO:0002577) | 3.20839948 |
| 88 | response to fungus (GO:0009620) | 3.20783594 |
| 89 | negative regulation of interleukin-12 production (GO:0032695) | 3.20166941 |
| 90 | microglial cell activation (GO:0001774) | 3.19573644 |
| 91 | cellular response to type I interferon (GO:0071357) | 3.17088829 |
| 92 | type I interferon signaling pathway (GO:0060337) | 3.17088829 |
| 93 | neutrophil migration (GO:1990266) | 3.16201758 |
| 94 | positive regulation of leukocyte degranulation (GO:0043302) | 3.15879476 |
| 95 | * production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15874409 |
| 96 | dendritic cell chemotaxis (GO:0002407) | 3.14781943 |
| 97 | myeloid leukocyte activation (GO:0002274) | 3.14778092 |
| 98 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.14234662 |
| 99 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.14168813 |
| 100 | response to type I interferon (GO:0034340) | 3.13758623 |
| 101 | macrophage activation (GO:0042116) | 3.13746665 |
| 102 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.12496141 |
| 103 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.11170419 |
| 104 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10897706 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09899374 |
| 106 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.09401830 |
| 107 | actin nucleation (GO:0045010) | 3.08647390 |
| 108 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07854055 |
| 109 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.07854055 |
| 110 | cellular response to exogenous dsRNA (GO:0071360) | 3.06420257 |
| 111 | myeloid leukocyte mediated immunity (GO:0002444) | 3.04023554 |
| 112 | cellular response to interferon-beta (GO:0035458) | 3.02295833 |
| 113 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02127571 |
| 114 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.00513632 |
| 115 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.00513632 |
| 116 | response to interferon-alpha (GO:0035455) | 3.00131617 |
| 117 | activated T cell proliferation (GO:0050798) | 3.00000805 |
| 118 | regulation of regulatory T cell differentiation (GO:0045589) | 2.99773576 |
| 119 | dendritic cell migration (GO:0036336) | 2.98559277 |
| 120 | tolerance induction (GO:0002507) | 2.98310263 |
| 121 | negative regulation of phagocytosis (GO:0050765) | 2.97978125 |
| 122 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96523883 |
| 123 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.96138761 |
| 124 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.95979186 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 2.95070592 |
| 126 | T cell selection (GO:0045058) | 2.94220600 |
| 127 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93562118 |
| 128 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.93100724 |
| 129 | positive T cell selection (GO:0043368) | 2.92297267 |
| 130 | cellular response to zinc ion (GO:0071294) | 2.91749342 |
| 131 | granulocyte chemotaxis (GO:0071621) | 2.89909583 |
| 132 | detection of bacterium (GO:0016045) | 2.89340013 |
| 133 | positive regulation of interferon-beta production (GO:0032728) | 2.88055466 |
| 134 | positive regulation of lymphocyte migration (GO:2000403) | 2.87778847 |
| 135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86080329 |
| 136 | B cell receptor signaling pathway (GO:0050853) | 2.85216189 |
| 137 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.84559922 |
| 138 | leukocyte mediated immunity (GO:0002443) | 2.82307490 |
| 139 | negative regulation of interleukin-17 production (GO:0032700) | 2.82166186 |
| 140 | positive regulation of T cell migration (GO:2000406) | 2.82143203 |
| 141 | detection of molecule of bacterial origin (GO:0032490) | 2.82074490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.51025584 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.99982633 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.22182909 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.99716197 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.97276309 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.82478743 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.76968301 |
| 8 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.51685056 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42823206 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.18006630 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.05400990 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.00314161 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.91083083 |
| 14 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.79787536 |
| 15 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.79111506 |
| 16 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.71033901 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.68481158 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.64519497 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58784553 |
| 20 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.51693448 |
| 21 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.48660042 |
| 22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.41561668 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40907600 |
| 24 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28765200 |
| 25 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19619230 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.13709828 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12112590 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.08987861 |
| 29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03405887 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00662473 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90389670 |
| 32 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.88530441 |
| 33 | * MYB_26560356_Chip-Seq_TH2_Human | 1.88290373 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87585022 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85525560 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76169861 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.72598643 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68544256 |
| 39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68520421 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63949901 |
| 41 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63213460 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62485379 |
| 43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61369524 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60870741 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56216860 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.55317299 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.54519338 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53933330 |
| 49 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47822935 |
| 50 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45067576 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43664412 |
| 52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42492432 |
| 53 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39379027 |
| 54 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36664764 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35131490 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33169925 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32576038 |
| 58 | MYC_22102868_ChIP-Seq_BL_Human | 1.30895176 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29918887 |
| 60 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.27830066 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27685273 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26206054 |
| 63 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25343242 |
| 64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25315939 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24554322 |
| 66 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21508348 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16518464 |
| 68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16362491 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14602767 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14562733 |
| 71 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14434409 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13542874 |
| 73 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.12848320 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07696639 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07560770 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07310795 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06999414 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03162204 |
| 79 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01589120 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01230449 |
| 81 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98521275 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98044481 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95046340 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 0.94685554 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91056160 |
| 86 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90500907 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89964163 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89198967 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87852064 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87533776 |
| 91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.86735009 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86155669 |
| 93 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.80725467 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78018541 |
| 95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77336366 |
| 96 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75619283 |
| 97 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74677224 |
| 98 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74563655 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74187466 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71833960 |
| 101 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.71408490 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70827642 |
| 103 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.69265912 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69114306 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68588485 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68082720 |
| 107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67450227 |
| 108 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.66748867 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66316166 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65889149 |
| 111 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.65132123 |
| 112 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.61927040 |
| 113 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61568205 |
| 114 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60805529 |
| 115 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.60736368 |
| 116 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.59515881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.97257111 |
| 2 | * MP0003436_decreased_susceptibility_to | 3.88308708 |
| 3 | MP0009785_altered_susceptibility_to | 3.66831050 |
| 4 | * MP0002148_abnormal_hypersensitivity_rea | 3.61747386 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.41301963 |
| 6 | MP0005025_abnormal_response_to | 3.15043424 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.12489214 |
| 8 | MP0003303_peritoneal_inflammation | 3.03008681 |
| 9 | MP0003724_increased_susceptibility_to | 2.92694392 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.76093033 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.75306501 |
| 12 | MP0000685_abnormal_immune_system | 2.73200604 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.70453486 |
| 14 | MP0005387_immune_system_phenotype | 2.67561469 |
| 15 | MP0001790_abnormal_immune_system | 2.67561469 |
| 16 | MP0005671_abnormal_response_to | 2.62838196 |
| 17 | MP0001800_abnormal_humoral_immune | 2.59647654 |
| 18 | MP0002723_abnormal_immune_serum | 2.54726195 |
| 19 | * MP0001819_abnormal_immune_cell | 2.45742380 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.44090507 |
| 21 | MP0006082_CNS_inflammation | 2.40777689 |
| 22 | MP0001853_heart_inflammation | 2.21677659 |
| 23 | MP0002405_respiratory_system_inflammati | 2.17780268 |
| 24 | MP0009278_abnormal_bone_marrow | 2.03977954 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.99346031 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.99346031 |
| 27 | MP0000343_altered_response_to | 1.96878653 |
| 28 | * MP0001533_abnormal_skeleton_physiology | 1.95569704 |
| 29 | * MP0001845_abnormal_inflammatory_respons | 1.93997416 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.89893161 |
| 31 | MP0000716_abnormal_immune_system | 1.84191278 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.83557886 |
| 33 | MP0002398_abnormal_bone_marrow | 1.82424882 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.80622663 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.77506652 |
| 36 | MP0004510_myositis | 1.76532183 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.71246035 |
| 38 | MP0003075_altered_response_to | 1.69953684 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.66672917 |
| 40 | MP0008469_abnormal_protein_level | 1.64164204 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.61611975 |
| 42 | MP0009764_decreased_sensitivity_to | 1.59527585 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.56905549 |
| 44 | MP0002429_abnormal_blood_cell | 1.56156621 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.53070452 |
| 46 | MP0004947_skin_inflammation | 1.48959797 |
| 47 | MP0002722_abnormal_immune_system | 1.48609837 |
| 48 | MP0005310_abnormal_salivary_gland | 1.41016785 |
| 49 | MP0002006_tumorigenesis | 1.39760301 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.38608236 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.38317803 |
| 52 | MP0000490_abnormal_crypts_of | 1.38299410 |
| 53 | MP0003448_altered_tumor_morphology | 1.38173620 |
| 54 | MP0000858_altered_metastatic_potential | 1.38045245 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.24106413 |
| 56 | MP0004381_abnormal_hair_follicle | 1.22508905 |
| 57 | MP0005166_decreased_susceptibility_to | 1.17935221 |
| 58 | MP0003828_pulmonary_edema | 1.17703467 |
| 59 | MP0009840_abnormal_foam_cell | 1.11988937 |
| 60 | MP0001873_stomach_inflammation | 1.10521594 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.08638670 |
| 62 | MP0003763_abnormal_thymus_physiology | 1.07699135 |
| 63 | MP0003866_abnormal_defecation | 1.07451609 |
| 64 | MP0003045_fibrosis | 1.06117652 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.04910045 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.03825283 |
| 67 | MP0005451_abnormal_body_composition | 1.03601052 |
| 68 | MP0001851_eye_inflammation | 1.01018094 |
| 69 | MP0002933_joint_inflammation | 1.00762183 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.99180811 |
| 71 | MP0009763_increased_sensitivity_to | 0.95511177 |
| 72 | MP0010307_abnormal_tumor_latency | 0.91973349 |
| 73 | * MP0005390_skeleton_phenotype | 0.90330683 |
| 74 | MP0003186_abnormal_redox_activity | 0.90164824 |
| 75 | MP0000015_abnormal_ear_pigmentation | 0.88503853 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 0.88384894 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 0.83194345 |
| 78 | MP0005164_abnormal_response_to | 0.82964118 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.81898546 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 0.81733264 |
| 81 | MP0000703_abnormal_thymus_morphology | 0.81244250 |
| 82 | MP0008004_abnormal_stomach_pH | 0.79845920 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.76577062 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.76422889 |
| 85 | MP0000249_abnormal_blood_vessel | 0.76399135 |
| 86 | MP0000371_diluted_coat_color | 0.76163988 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.76031751 |
| 88 | MP0001663_abnormal_digestive_system | 0.74720520 |
| 89 | MP0000569_abnormal_digit_pigmentation | 0.72589344 |
| 90 | MP0002132_abnormal_respiratory_system | 0.72435958 |
| 91 | MP0003690_abnormal_glial_cell | 0.72129468 |
| 92 | MP0003566_abnormal_cell_adhesion | 0.71171833 |
| 93 | MP0000604_amyloidosis | 0.70097269 |
| 94 | MP0002019_abnormal_tumor_incidence | 0.69384585 |
| 95 | MP0003795_abnormal_bone_structure | 0.67204522 |
| 96 | MP0004883_abnormal_blood_vessel | 0.64937295 |
| 97 | MP0008260_abnormal_autophagy | 0.63337549 |
| 98 | MP0000920_abnormal_myelination | 0.63193316 |
| 99 | MP0008873_increased_physiological_sensi | 0.59635464 |
| 100 | MP0006054_spinal_hemorrhage | 0.57420532 |
| 101 | MP0010352_gastrointestinal_tract_polyps | 0.56367146 |
| 102 | MP0008874_decreased_physiological_sensi | 0.53535840 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.52047321 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.51376069 |
| 105 | MP0000313_abnormal_cell_death | 0.50165401 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.49700364 |
| 107 | MP0001958_emphysema | 0.48999369 |
| 108 | MP0002693_abnormal_pancreas_physiology | 0.48037976 |
| 109 | MP0008007_abnormal_cellular_replicative | 0.47978485 |
| 110 | MP0005023_abnormal_wound_healing | 0.46903598 |
| 111 | MP0005076_abnormal_cell_differentiation | 0.46453163 |
| 112 | MP0000609_abnormal_liver_physiology | 0.45908249 |
| 113 | MP0004130_abnormal_muscle_cell | 0.45580899 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.42208955 |
| 115 | MP0002254_reproductive_system_inflammat | 0.40509078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.78689631 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.96078916 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.73311264 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.93336104 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.90553944 |
| 6 | Myositis (HP:0100614) | 4.84922338 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.69472585 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.53571144 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.46920114 |
| 10 | Obstructive lung disease (HP:0006536) | 4.43203312 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.43203312 |
| 12 | Recurrent skin infections (HP:0001581) | 4.37944165 |
| 13 | Abnormality of T cell number (HP:0011839) | 4.31198901 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 4.29966775 |
| 15 | T lymphocytopenia (HP:0005403) | 4.23441241 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.13322257 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 4.06123883 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.92830118 |
| 19 | Orchitis (HP:0100796) | 3.90285956 |
| 20 | Gingivitis (HP:0000230) | 3.85596196 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 3.63566252 |
| 22 | Optic neuritis (HP:0100653) | 3.59611062 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.59611062 |
| 24 | Cellulitis (HP:0100658) | 3.56531468 |
| 25 | Hypochromic microcytic anemia (HP:0004840) | 3.51610270 |
| 26 | Petechiae (HP:0000967) | 3.39319820 |
| 27 | Meningitis (HP:0001287) | 3.36367642 |
| 28 | Increased IgM level (HP:0003496) | 3.31399771 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.27058382 |
| 30 | Hypochromic anemia (HP:0001931) | 3.24773514 |
| 31 | Recurrent viral infections (HP:0004429) | 3.24771656 |
| 32 | IgM deficiency (HP:0002850) | 3.11561216 |
| 33 | Thrombocytosis (HP:0001894) | 3.09965286 |
| 34 | Stomatitis (HP:0010280) | 3.07663794 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.04912002 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.04912002 |
| 37 | Pustule (HP:0200039) | 2.96741968 |
| 38 | Vasculitis (HP:0002633) | 2.96348506 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.95543599 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.95543599 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.95543599 |
| 42 | Periodontitis (HP:0000704) | 2.95366715 |
| 43 | Agnosia (HP:0010524) | 2.95154222 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.90908113 |
| 45 | Glomerulonephritis (HP:0000099) | 2.89746770 |
| 46 | Urticaria (HP:0001025) | 2.88018517 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.86212100 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.85894129 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.85227515 |
| 50 | Disinhibition (HP:0000734) | 2.85060110 |
| 51 | Granulocytopenia (HP:0001913) | 2.84487401 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.81641110 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.79587651 |
| 54 | Axonal loss (HP:0003447) | 2.76685597 |
| 55 | Chronic otitis media (HP:0000389) | 2.66916398 |
| 56 | Epistaxis (HP:0000421) | 2.66827658 |
| 57 | Anorexia (HP:0002039) | 2.66373536 |
| 58 | Eosinophilia (HP:0001880) | 2.65814810 |
| 59 | Gangrene (HP:0100758) | 2.61868516 |
| 60 | Basal ganglia calcification (HP:0002135) | 2.61461687 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.57281922 |
| 62 | Episodic fever (HP:0001954) | 2.57256777 |
| 63 | Abnormality of the prostate (HP:0008775) | 2.54854378 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.53717447 |
| 65 | Lymphopenia (HP:0001888) | 2.53096816 |
| 66 | Prostate neoplasm (HP:0100787) | 2.52680589 |
| 67 | Arterial thrombosis (HP:0004420) | 2.48762517 |
| 68 | Poor head control (HP:0002421) | 2.47916558 |
| 69 | Abnormality of eosinophils (HP:0001879) | 2.47645416 |
| 70 | Gingival bleeding (HP:0000225) | 2.47127616 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.46621961 |
| 72 | Osteomyelitis (HP:0002754) | 2.44326662 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.40644083 |
| 74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.38498162 |
| 75 | Mucopolysacchariduria (HP:0008155) | 2.38498162 |
| 76 | Recurrent lower respiratory tract infections (HP:0002783) | 2.37934204 |
| 77 | Loss of speech (HP:0002371) | 2.37749837 |
| 78 | Hemoptysis (HP:0002105) | 2.37267721 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.37152258 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.37076785 |
| 81 | Leukocytosis (HP:0001974) | 2.35882543 |
| 82 | Joint swelling (HP:0001386) | 2.31648207 |
| 83 | Amyloidosis (HP:0011034) | 2.27273628 |
| 84 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26779535 |
| 85 | Encephalitis (HP:0002383) | 2.25531920 |
| 86 | Gastrointestinal inflammation (HP:0004386) | 2.24538149 |
| 87 | Colitis (HP:0002583) | 2.23747226 |
| 88 | Chest pain (HP:0100749) | 2.23446647 |
| 89 | Microcytic anemia (HP:0001935) | 2.23349873 |
| 90 | Recurrent bronchitis (HP:0002837) | 2.22358390 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21593801 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21593801 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21593801 |
| 94 | Premature loss of primary teeth (HP:0006323) | 2.19617938 |
| 95 | Hematochezia (HP:0002573) | 2.19479727 |
| 96 | Glomerulopathy (HP:0100820) | 2.18416689 |
| 97 | Hepatosplenomegaly (HP:0001433) | 2.17931899 |
| 98 | Keratoconjunctivitis (HP:0001096) | 2.17611907 |
| 99 | Panhypogammaglobulinemia (HP:0003139) | 2.17316369 |
| 100 | IgG deficiency (HP:0004315) | 2.17085603 |
| 101 | Purpura (HP:0000979) | 2.15430677 |
| 102 | Chronic diarrhea (HP:0002028) | 2.14973782 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 2.13749129 |
| 104 | Abnormal platelet function (HP:0011869) | 2.13734191 |
| 105 | Impaired platelet aggregation (HP:0003540) | 2.13734191 |
| 106 | Polyneuropathy (HP:0001271) | 2.12726889 |
| 107 | Abnormality of the pericardium (HP:0001697) | 2.10295354 |
| 108 | Joint hemorrhage (HP:0005261) | 2.07848431 |
| 109 | Increased serum ferritin (HP:0003281) | 2.07393189 |
| 110 | Thoracic kyphosis (HP:0002942) | 2.04512205 |
| 111 | Skin rash (HP:0000988) | 2.04427941 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 1.99858160 |
| 113 | Sepsis (HP:0100806) | 1.99718610 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 1.98374512 |
| 115 | Peritonitis (HP:0002586) | 1.98213316 |
| 116 | Skin ulcer (HP:0200042) | 1.97188409 |
| 117 | Severe combined immunodeficiency (HP:0004430) | 1.96545370 |
| 118 | Vertigo (HP:0002321) | 1.95462625 |
| 119 | Abnormality of the pleura (HP:0002103) | 1.93298724 |
| 120 | Abnormality of T cells (HP:0002843) | 1.92694691 |
| 121 | Albinism (HP:0001022) | 1.92591986 |
| 122 | Abnormality of the peritoneum (HP:0002585) | 1.91741838 |
| 123 | Nephritis (HP:0000123) | 1.91071714 |
| 124 | Pulmonary embolism (HP:0002204) | 1.90864011 |
| 125 | Increased IgE level (HP:0003212) | 1.90306404 |
| 126 | J-shaped sella turcica (HP:0002680) | 1.89995985 |
| 127 | Acne (HP:0001061) | 1.89892319 |
| 128 | Abnormality of the endocardium (HP:0004306) | 1.89881582 |
| 129 | Thick nail (HP:0001805) | 1.89567530 |
| 130 | Keratitis (HP:0000491) | 1.89004449 |
| 131 | Abnormality of complement system (HP:0005339) | 1.85396300 |
| 132 | Abnormality of the nasal mucosa (HP:0000433) | 1.85324978 |
| 133 | Agammaglobulinemia (HP:0004432) | 1.81320510 |
| 134 | Reduced antithrombin III activity (HP:0001976) | 1.79098993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.23127139 |
| 2 | IRAK4 | 4.09085259 |
| 3 | RIPK4 | 3.54941055 |
| 4 | MAP4K1 | 3.39669241 |
| 5 | KIT | 3.05586200 |
| 6 | MAP3K14 | 2.87418734 |
| 7 | TBK1 | 2.69860444 |
| 8 | IRAK3 | 2.63018772 |
| 9 | TEC | 2.51608570 |
| 10 | BTK | 2.41506537 |
| 11 | TYK2 | 2.28735939 |
| 12 | NME2 | 2.15633879 |
| 13 | TXK | 1.95698786 |
| 14 | CSF1R | 1.92755754 |
| 15 | IKBKE | 1.92700013 |
| 16 | IKBKB | 1.89612654 |
| 17 | TAOK3 | 1.86462414 |
| 18 | PIM2 | 1.83855086 |
| 19 | ZAP70 | 1.81172937 |
| 20 | TGFBR2 | 1.81031240 |
| 21 | JAK3 | 1.73770781 |
| 22 | ERN1 | 1.73337894 |
| 23 | SYK | 1.73307404 |
| 24 | TESK2 | 1.68193272 |
| 25 | CSK | 1.66131774 |
| 26 | MAP2K3 | 1.62439994 |
| 27 | FES | 1.59790081 |
| 28 | MAP3K12 | 1.46713719 |
| 29 | HCK | 1.46200969 |
| 30 | MATK | 1.44809598 |
| 31 | LYN | 1.44798979 |
| 32 | CLK1 | 1.40418552 |
| 33 | MAP3K3 | 1.37876737 |
| 34 | TAOK1 | 1.33359999 |
| 35 | PRPF4B | 1.33049002 |
| 36 | FLT3 | 1.32162758 |
| 37 | EPHB1 | 1.27682437 |
| 38 | STK10 | 1.27613154 |
| 39 | PIM1 | 1.21992783 |
| 40 | TRPM7 | 1.15424914 |
| 41 | NEK9 | 1.13864115 |
| 42 | LCK | 1.11691181 |
| 43 | CDK19 | 1.03523197 |
| 44 | MAP3K1 | 1.03196653 |
| 45 | JAK1 | 1.03059781 |
| 46 | FGR | 0.98605871 |
| 47 | GRK7 | 0.97893926 |
| 48 | ITK | 0.95920382 |
| 49 | RPS6KA4 | 0.95905762 |
| 50 | CHUK | 0.93284578 |
| 51 | JAK2 | 0.86623832 |
| 52 | LRRK2 | 0.81627683 |
| 53 | ADRBK2 | 0.81601575 |
| 54 | PRKCQ | 0.80850733 |
| 55 | YES1 | 0.78665717 |
| 56 | PDPK1 | 0.76174112 |
| 57 | PBK | 0.75451842 |
| 58 | PIK3CA | 0.74441397 |
| 59 | ABL2 | 0.72794816 |
| 60 | MAP3K11 | 0.71027020 |
| 61 | STK4 | 0.70517858 |
| 62 | PRKCD | 0.69849537 |
| 63 | KSR2 | 0.68953657 |
| 64 | PAK4 | 0.66998951 |
| 65 | MAPK12 | 0.64749182 |
| 66 | EIF2AK2 | 0.64645006 |
| 67 | MAP3K13 | 0.64546176 |
| 68 | BMPR2 | 0.63135140 |
| 69 | ERBB3 | 0.61387728 |
| 70 | RPS6KA6 | 0.60368719 |
| 71 | EPHA3 | 0.59290163 |
| 72 | GRK6 | 0.57837484 |
| 73 | ABL1 | 0.57135338 |
| 74 | PIK3CG | 0.55764267 |
| 75 | KDR | 0.54515808 |
| 76 | TGFBR1 | 0.53467293 |
| 77 | MARK2 | 0.52210793 |
| 78 | PKN2 | 0.52055510 |
| 79 | MAPKAPK2 | 0.50834723 |
| 80 | PRKG2 | 0.50140766 |
| 81 | MOS | 0.50054948 |
| 82 | CAMKK2 | 0.48418254 |
| 83 | RPS6KL1 | 0.48236797 |
| 84 | RPS6KC1 | 0.48236797 |
| 85 | TLK1 | 0.47501305 |
| 86 | IRAK2 | 0.47184861 |
| 87 | PTK6 | 0.45773404 |
| 88 | PRKD2 | 0.45753743 |
| 89 | RET | 0.45059839 |
| 90 | SIK2 | 0.44651281 |
| 91 | STK24 | 0.44483883 |
| 92 | MUSK | 0.43786289 |
| 93 | MARK3 | 0.43180632 |
| 94 | MAPK4 | 0.42769455 |
| 95 | HIPK2 | 0.40973905 |
| 96 | BMX | 0.40721809 |
| 97 | EGFR | 0.40374139 |
| 98 | TAOK2 | 0.40111258 |
| 99 | SCYL2 | 0.39805269 |
| 100 | IRAK1 | 0.38423276 |
| 101 | PDK1 | 0.35324610 |
| 102 | MAP3K2 | 0.35314913 |
| 103 | MAP2K6 | 0.34999073 |
| 104 | TNK2 | 0.34764236 |
| 105 | STK11 | 0.34719252 |
| 106 | SIK3 | 0.34598988 |
| 107 | MAPK7 | 0.34024611 |
| 108 | MAP3K6 | 0.33400300 |
| 109 | FGFR4 | 0.33125378 |
| 110 | MAP3K5 | 0.32970694 |
| 111 | DAPK1 | 0.32894971 |
| 112 | CDK6 | 0.30744588 |
| 113 | EIF2AK3 | 0.30718855 |
| 114 | FGFR3 | 0.30560070 |
| 115 | MAP2K4 | 0.28310672 |
| 116 | VRK1 | 0.28078005 |
| 117 | PTK2B | 0.27727563 |
| 118 | RIPK1 | 0.27524213 |
| 119 | MST1R | 0.26799052 |
| 120 | DAPK2 | 0.26339405 |
| 121 | TIE1 | 0.25884141 |
| 122 | MKNK1 | 0.25218844 |
| 123 | CAMK1D | 0.24953581 |
| 124 | FYN | 0.24657815 |
| 125 | MAPKAPK5 | 0.24572010 |
| 126 | NLK | 0.24089470 |
| 127 | CAMKK1 | 0.23868671 |
| 128 | CDC42BPA | 0.23617161 |
| 129 | IGF1R | 0.23398559 |
| 130 | INSR | 0.23016623 |
| 131 | MAP3K7 | 0.21090127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.61346356 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.59231659 |
| 3 | Legionellosis_Homo sapiens_hsa05134 | 2.53427319 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48512523 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.48483880 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.48462390 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.42919351 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38538926 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19651703 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.18285756 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.18281543 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.11267051 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.07780209 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.98164827 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.96232156 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.90049462 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.89209447 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.89078937 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88385530 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.79640506 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.75532166 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73880510 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69673318 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.69500282 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68245306 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.64312941 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58054633 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.55112038 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54262805 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.54214689 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53426962 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52377545 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50443876 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43713728 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41288800 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33278764 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33163869 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.32506624 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31822640 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28047775 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26746967 |
| 42 | DNA replication_Homo sapiens_hsa03030 | 1.26323733 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23058351 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20543575 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.10207862 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.07906518 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99425778 |
| 48 | Ribosome_Homo sapiens_hsa03010 | 0.94612779 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94511505 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94404994 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93116899 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88616130 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87018601 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83875481 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83786462 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82602649 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81902422 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79482909 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.78924326 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77974440 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75531613 |
| 62 | Base excision repair_Homo sapiens_hsa03410 | 0.74886148 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74678595 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.72281114 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68709832 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65253978 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.64245788 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63555254 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.63360889 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61611979 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61076026 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.58417671 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58022966 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57952278 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57687987 |
| 76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56081461 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55039282 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54522609 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51862295 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49499431 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48199957 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46560891 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46053060 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43700339 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42852898 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42156334 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39475825 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39443376 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39418747 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39229823 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38018233 |
| 92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36887989 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34752113 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34292853 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33362012 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32807590 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31637388 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29775329 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29376064 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28764144 |
| 101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.28401493 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27908742 |
| 103 | Proteasome_Homo sapiens_hsa03050 | 0.27807030 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27001526 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24832980 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24767038 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24723418 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.24573853 |
| 109 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.24226080 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23446637 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.22786314 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20912002 |
| 113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20905911 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19778753 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19642333 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19048164 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18969577 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18157825 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.17789976 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17707234 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15603634 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.14960814 |

